These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 18645702)

  • 41. Using statins to reduce cardiovascular risk after carotid endarterectomy.
    Floros G; Anagnostou V; Tsiga E; Ferenidou F; Papadimitriou D
    Evid Based Cardiovasc Med; 2006 Mar; 10(1):1-4. PubMed ID: 16530653
    [No Abstract]   [Full Text] [Related]  

  • 42. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 43. Lipoprotein metabolism and lipid management in chronic kidney disease.
    Kwan BC; Kronenberg F; Beddhu S; Cheung AK
    J Am Soc Nephrol; 2007 Apr; 18(4):1246-61. PubMed ID: 17360943
    [No Abstract]   [Full Text] [Related]  

  • 44. Dyslipidaemia, statins and rheumatoid arthritis.
    Nurmohamed MT; Dijkmans BA
    Ann Rheum Dis; 2009 Apr; 68(4):453-5. PubMed ID: 19286903
    [No Abstract]   [Full Text] [Related]  

  • 45. Will obesity increase the proportion of children and adolescents recommended for a statin?
    McCrindle BW; Tyrrell PN; Kavey RE
    Circulation; 2013 Nov; 128(19):2162-5. PubMed ID: 24190936
    [No Abstract]   [Full Text] [Related]  

  • 46. Overcoming Challenges With Statin Therapy.
    Spence JD; Dresser GK
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26819251
    [No Abstract]   [Full Text] [Related]  

  • 47. Modulation of heat shock proteins by statins.
    Forouzanfar F; Butler AE; Banach M; Barreto GE; Sahbekar A
    Pharmacol Res; 2018 Aug; 134():134-144. PubMed ID: 29935271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
    Ponte B; Bourquin V; Stoermann-Chopard C
    Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of statins on renal function].
    Kasahara M
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1295-300. PubMed ID: 24288966
    [No Abstract]   [Full Text] [Related]  

  • 51. Reinitiation of statins after statin-associated musculoskeletal symptoms: a patient-centered approach.
    Brito JP; Montori VM
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):243-7. PubMed ID: 23481527
    [No Abstract]   [Full Text] [Related]  

  • 52. HMG CoA reductase inhibitors and renoprotection: the weight of the evidence.
    Romayne Kurukulasuriya L; Athappan G; Saab G; Whaley Connell A; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):49-59. PubMed ID: 19124395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 54. Starting statins for primary prevention of cardiovascular disease.
    Tunstall-Pedoe H
    Heart; 2013 Nov; 99(21):1547-8. PubMed ID: 23878178
    [No Abstract]   [Full Text] [Related]  

  • 55. The role of statins in the setting of HIV infection.
    Eckard AR; McComsey GA
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins for primary prevention: problems with cardiovascular-risk estimation?
    Reiner Ž
    Nat Rev Cardiol; 2013 Sep; 10(9):547. PubMed ID: 23880954
    [No Abstract]   [Full Text] [Related]  

  • 57. [Osteoporosis and atherosclerosis].
    Omura Y; Nishio Y; Kashiwagi A
    Clin Calcium; 2007 Mar; 17(3):346-53. PubMed ID: 17339738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
    Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
    [No Abstract]   [Full Text] [Related]  

  • 59. Preventive cardiology and cardiac rehabilitation programmes in women.
    Ll Lloyd GW
    Maturitas; 2009 May; 63(1):28-33. PubMed ID: 19321277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statins for primary prevention: identifying low-risk individuals.
    Huang YL; Huang Y; Wu YX
    Nat Rev Cardiol; 2013 Sep; 10(9):547. PubMed ID: 23880953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.